As of 2:30 PM on the 17th, Celltrion is trading at 323,500 KRW, down 0.46% from the previous day. This represents a 12.8% decline compared to February 1st. Celltrion is known as a protein and biopharmaceutical manufacturing company.

Today, foreigners have a net purchase of 15,000 shares of Celltrion, while institutions have a net sale of 22,000 shares, according to provisional data. Over the past five days, individual investors have net purchased 291,338 shares, foreigners have net purchased 13,046 shares, and institutions have net sold 313,008 shares respectively.


On February 8th, Celltrion was a market topic with the headline "Strong performance following MFDS approval of COVID-19 antibody treatment."





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing